Oak Street Health, Inc. (OSH) is Being Investigated for Violating the False Claims Act    A shareholder filed a class action on behalf of all persons and entities that purchased

Clarivate Plc (CLVT) Maintained Defective Controls and Procedures A class action has been filed on behalf of all persons and entities that purchased or otherwise or acquired Clarivate Plc (NYSE:

Standard Lithium Ltd. (SLI) Overstated its Lithium Recovery Rates     A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired Standard Lithium Ltd. (NYSE:

Aligos Therapeutics, Inc. (ALGS) Halted Development of its Lead Drug Candidate Robbins LLP is investigating Aligos Therapeutics, Inc. (NASDAQ: ALGS) to determine whether certain Aligos officers and directors violated securities laws

TaskUs, Inc.’s (TASK) Business Prospects Questioned in Spruce Point Report Robbins LLP is investigating TaskUs, Inc. (NASDAQ: TASK) to determine whether certain TaskUs officers and directors violated the Securities Exchange

NRx Pharmaceutical, Inc. (NRXP) Misled Investors Regarding the EUA Status of its Drug Candidate    A shareholder filed a class action on behalf of all persons who purchased or otherwise

Gatos Silver, Inc. (GATO) Announces Errors in Mineral Resource and Reserve Estimates in its 2020 Technical Report Robbins LLP is investigating Gatos Silver, Inc. (NYSE: GATO) to determine whether certain

ChemoCentryx, Inc. (CCXI) Misled Investors Regarding the Company’s Concerns for User Safety On November 25, 2019, ChemoCentryx, Inc. (CCXI) announced “Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating

KE Holdings, Inc. is Accused of Disseminating False and Misleading Information Regarding Transaction Volumes, Store Count and Agent Count, and Transaction Data   Robbins LLP has filed a class action